Buzz Stocks: Deere & Company, HP Inc, and BioMarin Pharmaceuticals Inc.

Today's stocks to watch include Deere & Company (DE), HP Inc (HPQ), and BioMarin Pharmaceutical Inc. BMRN)

Nov 25, 2015 at 9:44 AM

BMRN
HPE
HPQ
DE

U.S. stocks are pointed higher this morning on a fresh round of economic data, even as crude oil slides back from yesterday's win. Among the equities in focus are agricultural equipment maker Deere & Company (NYSE:DE), tech concern HP Inc (NYSE:HPQ), and biotech interest BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

DE is 4.5% higher at $79.80 this morning, after announcing quarterly earnings that beat estimates on the Street, even though revenue fell short. The last time Deere & Company reported earnings -- in late August -- it forecast lower sales for the 2015 fiscal year, sending the shares to a one-day loss of 8.1%. This time around, though, bears could be sweating; currently, 12% of DE's float is sold short, and it would take nearly two full weeks of trading to cover those positions at the stock's typical daily volume.

HPQ reported quarterly earnings last night, for the first time since the company began trading separately from Hewlett-Packard Enterprise Co (NYSE:HPE). Unfortunately, earnings and revenue came in below expectations, dropping HP Inc 12.8% to $12.77 this morning. The company has been having a rough time for most of the year, losing nearly one-third of its value so far in 2015, and underperforming the S&P 500 Index (SPX) by more than 50 percentage points over the past three months -- though the shares have been trending higher since the company split. Options traders have remained pessimistic, as the stock's 10-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is just one percentage point shy of a 52-week high, at 2.99.

It's a disappointing morning for BMRN, as the U.S. Food and Drug Administration (FDA) reported that data on its muscle wastage treatment is not strong enough for approval. Today the shares have shed 2.9% to trade at $94.99. Just last week, the FDA raised questions over the effects of the same drug in young children. The company is up 5.1% so far this year, but has lost about one-third of its value since hitting a high of $151.75 in July.

Follow @Schaeffers

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?